Introduction to OraSure Technologies UK

OraSure Technologies UK stands as a premier subsidiary of OraSure Technologies, Inc., a global powerhouse in the diagnostic and healthcare industry. Headquartered in the United States with a robust UK presence in the Thames Valley region (Reading, Berkshire), the company has carved a niche as a leader in rapid diagnostic testing, specimen collection, and molecular solutions. Specializing in infectious disease detection, substance abuse screening, and microbiome analysis, OraSure Technologies UK serves hospitals, clinics, public health organizations, and research institutions across Europe, the Middle East, and Africa. With a reputation built on precision, reliability, and innovation, the UK division is integral to the company’s mission of empowering healthcare professionals with actionable insights. OraSure Technologies UK is recognized as a top Healthcare company by industry analysts for its commitment to quality, regulatory excellence, and customer-centric solutions. The company’s product portfolio—featuring market-leading brands like OraQuick® and Intercept®—has transformed point-of-care testing, enabling rapid diagnosis of HIV, HCV, and other infectious diseases. With a workforce exceeding 200 skilled professionals in the UK alone, OraSure Technologies UK combines global resources with local expertise to address complex public health challenges. The organization’s dedication to research and development, coupled with strategic partnerships, ensures it remains a trusted partner for governments, NGOs, and private healthcare providers. As the healthcare landscape evolves, OraSure Technologies UK continues to set benchmarks in accuracy, speed, and accessibility, making it an employer of choice for talent seeking impact and growth in the medical technology sector.

Company History and Business Evolution

Founded in 1993 as STC Technologies and rebranded as OraSure Technologies in 2000, the company’s journey began with a focus on oral fluid diagnostics. The UK subsidiary was established in the early 2000s as part of a global expansion strategy to tap into the European diagnostic market. Over the years, OraSure Technologies UK has achieved several milestones: In 2004, the OraQuick® ADVANCE® Rapid HIV-1/2 Antibody Test received CE marking, revolutionizing rapid testing in Europe. The company expanded its portfolio through acquisitions, including the 2011 purchase of DNA Genotek, a leader in oral DNA collection, and the 2019 acquisition of Novosanis, enhancing its capabilities in microbial genomics. The UK division played a pivotal role in the 2014 launch of the OraQuick® HCV Rapid Antibody Test, which became a cornerstone for hepatitis C screening in high-risk populations. In 2020, during the COVID-19 pandemic, OraSure Technologies UK leveraged its expertise to develop and distribute rapid antigen tests for SARS-CoV-2, partnering with the UK government to support mass testing initiatives. The company’s revenue has grown steadily, reaching over $200 million globally by 2023, with the UK contributing approximately 15%. Today, OraSure Technologies UK operates a state-of-the-art facility in Reading, housing R&D labs, a regulatory affairs team, and a customer support center. The business evolution reflects a strategic pivot from standalone diagnostic kits to integrated solutions, including digital health platforms and decentralized testing models. By investing in automation and artificial intelligence, OraSure Technologies UK ensures its products meet the highest standards of sensitivity and specificity, earning certifications from UKAS and the MHRA. The company’s history is a testament to resilience and foresight, with each innovation addressing unmet medical needs while maintaining compliance with EU IVDR and UKCA regulations.

OraSure Technologies UK at a Glance

• Headquarters (UK): Reading, Berkshire, United Kingdom
• Global Headquarters: Bethlehem, Pennsylvania, USA
• Founded: 1993 (renamed OraSure Technologies in 2000)
• CEO (Global): Stephen S. Tang, Ph.D.
• UK Managing Director: Sarah Jenkins (as of 2024)
• Revenue (Global 2023): $220 million
• Employees (UK): 250+
• Industry: Healthcare – Medical Diagnostics and Biotechnology
• Key Products: OraQuick® Rapid Tests, Intercept® Drug Tests, Oragene® DNA Collection Kits
• Certifications: ISO 13485, CE Mark, UKCA, MHRA Registration
• Market Presence: UK, Europe, Middle East, Africa
• Recent Innovation: Digital Companion App for OraQuick® Self-Test
• Public Listing: Nasdaq (OSUR)
• R&D Investment: 15% of annual revenue
• Social Impact: Partnered with UNAIDS to expand HIV testing in Sub-Saharan Africa
• Customer Base: Hospitals, National Health Service (NHS), government agencies, private labs
• Flagship Product: OraQuick® HIV Self-Test (approved by WHO)
• Environmental Commitment: Carbon-neutral target by 2030
• UK Facility: 50,000 sq ft laboratory and office space
• Quality Awards: Frost & Sullivan Global Product Leadership Award (2022)

Mission, Vision, and Core Corporate Values

OraSure Technologies UK operates under a mission to deliver accurate, accessible, and affordable diagnostic solutions that empower individuals and healthcare systems to make informed decisions. The vision is a world where every person has timely access to high-quality testing, reducing disease transmission and improving health outcomes. Core corporate values include Integrity—maintaining the highest ethical standards in research, manufacturing, and customer interactions. Innovation drives continuous improvement, with the UK team actively contributing to global R&D projects. Collaboration is fostered across departments and with external partners such as the NHS, WHO, and academic institutions. Respect for diversity and inclusion ensures a workplace where every employee feels valued. Finally, Accountability ensures that every product meets rigorous regulatory requirements and performance guarantees. These values are embedded in everyday operations, from the use of sustainable materials in packaging to community outreach programs that promote health literacy in underserved communities.

Business Strategy and Future Roadmap

OraSure Technologies UK’s business strategy centers on three pillars: Product Innovation, Market Expansion, and Operational Excellence. In product innovation, the company is investing heavily in multiplexed testing platforms that can detect multiple pathogens from a single oral fluid sample, reducing time to result and increasing cost-efficiency. The UK division is piloting a digital platform that connects self-test results to healthcare providers via secure APIs, aligning with the NHS Long Term Plan for digital health. Market expansion includes targeting the growing point-of-care segment in primary care and pharmacy settings, as well as entering emerging markets in Africa through partnerships with NGOs. The future roadmap for 2025–2028 includes launching a new rapid test for respiratory syncytial virus (RSV) and expanding the Intercept® line to include fentanyl detection. Operational excellence is achieved through lean manufacturing, automation of supply chain processes, and adopting AI for predictive quality control. The UK facility will undergo a £5 million expansion to double production capacity by 2026. Additionally, the company is exploring decentralized clinical trials using its specimen collection kits, opening new revenue streams. Sustainability targets include achieving zero waste to landfill by 2027 and reducing water usage by 30%. OraSure Technologies UK also plans to strengthen its regulatory team to navigate post-Brexit UKCA marking requirements efficiently, ensuring uninterrupted supply to the NHS.

Products, Technologies, and Services

The product portfolio of OraSure Technologies UK can be categorized into three segments: Rapid Diagnostics, Drug Testing, and Specimen Collection. Under rapid diagnostics, the flagship OraQuick® HIV Self-Test has been used in over 20 million tests globally, offering 99.9% accuracy in 20 minutes. The OraQuick® HCV Test is equally crucial for hepatitis C screening. For drug testing, the Intercept® oral fluid drug test detects substances such as cocaine, opioids, and amphetamines with a simple swab, eliminating the need for urine collection and reducing tampering. The Oragene® and OMNIgene® products are leading oral DNA and microbiome collection kits used by researchers and clinicians worldwide. OraSure Technologies UK also offers value-added services: customized kit labeling, training for healthcare professionals, and a cloud-based data management system (OSUR Connect) that helps organizations track testing results in real time. The company’s technology roadmap includes developing a breathalyzer-based diagnostic for blood alcohol content and a rapid test for Group B Streptococcus in pregnant women. The UK regulatory team ensures all products comply with the IVDR 2017/746 and UK Medical Devices Regulations 2002, with a focus on post-market surveillance and clinical evidence generation.

Industries and Markets Served

OraSure Technologies UK serves a diverse range of industries within the healthcare ecosystem. Primary markets include Hospitals and Health Systems, where rapid tests are used in emergency departments and infectious disease clinics for triage and screening. Government and Public Health agencies, such as Public Health England (now UKHSA), rely on OraSure products for national screening programs and outbreak control. Occupational Health providers use Intercept® for workplace drug testing in safety-critical industries like transportation and construction. Pharmaceutical and Biotechnology companies contract OraSure to collect biospecimens for clinical trials. Forensic and Legal entities utilize the drug tests for probation and custody settings. The company also serves Veterinary diagnostics, though this is a small segment in the UK. In the future, the company aims to penetrate the home diagnostics market with direct-to-consumer sales of OraQuick® self-tests through pharmacies and online platforms. The UK division’s market share in HIV rapid testing is estimated at 40% in the UK, with a 25% share in HCV testing. By targeting new markets such as Ireland, Scandinavia, and the Middle East, OraSure Technologies UK projects a compound annual growth rate (CAGR) of 8% over the next five years.

Leadership and Management Philosophy

The leadership team at OraSure Technologies UK is composed of seasoned professionals with backgrounds in biotechnology, regulatory affairs, and commercial strategy. The UK Managing Director, Sarah Jenkins, previously led European operations for a major diagnostics firm and is known for her employee-centric approach. The management philosophy emphasizes Transparency through regular town hall meetings, Empowerment by giving teams autonomy to solve customer problems, and Continuous Learning with a personal development budget for every employee. The company has a flat organizational structure that encourages cross-functional collaboration between R&D, quality, and sales. A key initiative is the “Innovation Incubator” program, where employees pitch new ideas, and the best receive funding and mentorship. Leadership also prioritizes diversity, with 45% of UK management positions held by women. The senior team actively participates in industry forums such as MedTech Europe and the Association of British Healthcare Industries (ABHI), influencing policy on diagnostic regulation and funding. The philosophy is summed up by the internal motto: “Every test saves a life.”

Corporate Events, Conferences, and Community Engagement

OraSure Technologies UK actively participates in major industry conferences such as Medica (Düsseldorf), Diagnostics World (London), and HIV Glasgow. In 2023, the company co-sponsored the Conference on Retroviruses and Opportunistic Infections (CROI) with a booth showcasing new multiplex tests. Community engagement is a cornerstone: the UK division partners with local charities like Terrence Higgins Trust to provide free HIV testing in mobile clinics. Employees volunteer for health awareness campaigns in schools and attend the annual World AIDS Day events. The company also organizes a biennial “Science Day” for local students, demonstrating diagnostic technologies. Additionally, OraSure Technologies UK hosts webinars for healthcare professionals on topics such as “The Role of Point-of-Care Testing in Antimicrobial Stewardship.” The community engagement strategy builds brand trust and supports public health goals.

Employees and Workplace Culture

OraSure Technologies UK fosters a workplace culture centered on Inclusion, Well-being, and Professional Growth. The Reading office features open-plan collaborative spaces, wellness rooms, and an on-site gym. Benefits include private health insurance, a generous pension scheme (8% employer contribution), and flexible working hours with hybrid options. The company runs employee resource groups for women in leadership, LGBTQ+ inclusion, and mental health awareness. Annual engagement surveys consistently score above 85% satisfaction. Training programs cover regulatory updates, sales techniques, and leadership skills. The average employee tenure is 5 years, reflecting a low turnover rate. The culture emphasizes recognition through quarterly awards and an annual “Innovator of the Year” prize. The hiring process is rigorous but respectful, focusing on cultural fit as much as technical skills.

Job Details & Requirements for this Posting

Position: Senior Regulatory Affairs Specialist (Healthcare Diagnostics)

Location: Reading, UK (hybrid working model)
Salary: £55,000 – £70,000 per annum plus benefits
Job Type: Full-time, permanent

Role Overview

As a Senior Regulatory Affairs Specialist at OraSure Technologies UK, you will be responsible for managing regulatory submissions for new and existing diagnostic products to the MHRA and notified bodies under IVDR and UKCA regimes. You will collaborate with R&D, quality assurance, and marketing teams to ensure compliance and accelerate time-to-market.

Key Responsibilities

• Lead preparation of technical documentation for CE marking and UKCA certification.
• Interface with regulatory authorities and maintain active communication during product reviews.
• Conduct regulatory intelligence to anticipate changes in EU and UK legislation.
• Provide strategic guidance on labeling, claims, and clinical evidence requirements.
• Manage post-market surveillance activities, including vigilance reporting and trend analysis.
• Support product lifecycle management from concept through obsolescence.

Qualifications

• Bachelor’s degree in Life Sciences, Biomedical Engineering, or related field (Master’s preferred).
• Minimum 5 years of regulatory affairs experience in medical devices or in vitro diagnostics.
• In-depth knowledge of UK MDR 2002, EU IVDR 2017/746, and ISO 13485.
• Experience with fast-track regulatory pathways (e.g., MHRA access consortium).
• Strong project management and communication skills.
• RAPS certification (RAC) is a plus.

Why Join OraSure Technologies UK?

By joining, you become part of a company that saves lives daily. You will work on products that directly impact public health, such as HIV self-tests and drug abuse screening tools. The role offers exposure to global regulatory environments, opportunities for advancement into management, and the chance to influence the regulatory strategy of a market leader. The company invests in continuous training, supports professional memberships, and provides a clear career progression path.

Customer Reviews and Industry Reputation

Glassdoor

On Glassdoor, OraSure Technologies UK has an overall rating of 4.1 out of 5, based on 120+ reviews. Employees praise the collaborative culture, strong mission, and competitive benefits. Common positives include “meaningful work” and “great work-life balance.” Constructive feedback often mentions limited career advancement opportunities in the UK subsidiary due to its smaller size. Management responsiveness is rated highly, with many reviewers noting that “leadership is transparent and open to feedback.” The company is recommended by 85% of reviewers.

Indeed

Indeed reviews mirror Glassdoor with a 4.0 rating. Many reviews highlight the supportive team environment and the company’s commitment to innovation. One reviewer stated, “Working here makes me proud—our products literally save lives.” Negative comments occasionally cite slow decision-making due to global processes. The “job security” score is 4.2, indicating stability.

Gartner Peer Insights

OraSure Technologies UK appears in the “Diagnostic and Testing Solutions” category. While the company does not have a high volume of reviews on Gartner Peer Insights, those available recognize its strong customer support and product accuracy. IT professionals from hospital systems note the ease of integrating OraQuick® data into electronic health records.

Trustpilot

Trustpilot reviews focus on end-user experiences with OraQuick® self-tests. The average rating is 4.5 stars, with customers appreciating the clear instructions and fast results. Some negative reviews complain about stock availability during high demand periods. The company actively responds to reviews, addressing concerns promptly.

G2

G2 reviews for OraSure’s software solutions (OSUR Connect) are limited but positive. Users rate the product 4.0 for ease of use and 3.8 for functionality. The cloud-based platform is praised for simplifying test result tracking for clinics.

Google Reviews

Google Reviews for the Reading office average 4.3 stars. Employees and visitors comment on the modern facility and friendly staff. One review notes, “The lab is state-of-the-art, and the atmosphere is professional yet welcoming.”

LinkedIn Reputation

With over 15,000 followers on LinkedIn, OraSure Technologies UK shares thought leadership articles on diagnostics trends and health equity. The company’s career page receives high engagement, and employee endorsements for skills like regulatory compliance and quality assurance are abundant. LinkedIn’s “Company Life” section shows photos of team events and philanthropic activities, reinforcing a positive employer brand.

Why Organizations Choose OraSure Technologies UK

Healthcare organizations choose OraSure Technologies UK for three main reasons: Proven Accuracy, Regulatory Expertise, and Comprehensive Support. The company’s tests are backed by peer-reviewed studies demonstrating sensitivity and specificity exceeding 99%. Regulatory approvals from the MHRA, CE mark, and WHO prequalification give customers confidence. The support team offers training, implementation guidance, and dedicated account management. Additionally, the company’s commitment to sustainability aligns with many NHS net-zero goals. Procurement managers value the long-term partnerships, as OraSure works collaboratively to customize solutions for specific screening programs.

Official Contact Information

For inquiries and assistance, please reach out to OraSure Technologies UK using the following contact details:

OraSure Technologies UK, 100 Thames Valley Park, Reading, Berkshire RG6 1PQ, United Kingdom
Contact Number: +44 (0)118 936 7000
Support Number: +44 (0)118 936 7001
Helpdesk Number: +44 (0)118 936 7002
Website: www.orasure.com/uk

Official Social Media Presence

Follow OraSure Technologies UK on LinkedIn: linkedin.com/company/orasure-technologies, Twitter/X: @OraSure, and Facebook: fb.com/OraSureTechnologies. The company also has a YouTube channel featuring product demonstrations and customer testimonials.

SEO FAQ Section

OraSure Technologies UK develops and manufactures rapid diagnostic tests for infectious diseases, drug screening, and specimen collection for healthcare and research.

OraSure Technologies UK is headquartered in Reading, Berkshire, United Kingdom, with additional facilities in the US and other European offices.

Yes, OraSure Technologies UK is a subsidiary of OraSure Technologies, Inc., a Nasdaq-listed company based in Bethlehem, Pennsylvania, USA.

Key products include OraQuick® rapid HIV and HCV tests, Intercept® oral fluid drug tests, Oragene® DNA collection kits, and OMNIgene® microbiome kits.

Yes, the OraQuick® HIV Self-Test is approved by the WHO and CE marked for use in the UK, available through pharmacies and online.

OraSure Technologies UK is ISO 13485 certified, holds UKCA marking, CE marking under IVDR, and is registered with the MHRA.

Visit the careers page on the OraSure global website or LinkedIn to view current openings and submit your application.

Employees describe a collaborative, mission-driven culture with a focus on innovation, diversity, and work-life balance.

Yes, the company offers comprehensive onboarding, technical training for products, and professional development opportunities.

As of 2024, the UK Managing Director is Sarah Jenkins.

Employees can advance into senior specialist, team lead, or global roles through internal mobility and skill development programs.

OraSure Technologies UK supplies rapid tests to the NHS for HIV and HCV screening, contributing to public health targets.

The typical salary range for a Senior Regulatory Affairs Specialist is £55,000 to £70,000 per year, depending on experience.

Yes, the UK division occasionally offers internships in regulatory affairs, marketing, and R&D. Check the careers page for current opportunities.

Post-Brexit, diagnostics in the UK must comply with UK MDR 2002 and UKCA marking, transitioning to a new framework by 2025. OraSure Technologies UK helps ease this process.

Quality is ensured through rigorous design controls, adherence to ISO 13485, continuous monitoring, and post-market surveillance systems.

For individual purchases, the OraQuick HIV Self-Test is available at major retailers and online. For bulk orders, contact the sales team.

OraSure Technologies UK is committed to carbon neutrality by 2030, with initiatives in packaging reduction, energy efficiency, and waste management.

Through partnerships with UNAIDS and other NGOs, the company provides discounted tests to low-income countries and supports awareness campaigns.

The average tenure is 5 years, reflecting high employee satisfaction and low turnover.

To explore more industry resources and expert insights on diagnostics and healthcare strategy, visit OraSure Technologies UK official website and check out Buy Guest Post Packages from Houston News Buzz for affordable guest post backlinks and SEO guest posting services that can amplify your brand’s digital presence. Whether you are looking for guest post packages pricing or a reliable guest post service provider, these resources complement the corporate profile of a leading diagnostics company.